Joseph Schwartz

Stock Analyst at Leerink Partners

(0.89)
# 2289
Out of 5,383 analysts
181
Total ratings
Success rate
Average return
43 Stocks
Name Action PT Current % Upside Ratings Updated
INSM Insmed
Maintains: Outperform
100 115
100.52 14.41% 4 Jun 10, 2025
FULC Fulcrum Therapeutics
Upgrades: Outperform
4 12
7.1 69.01% 4 May 23, 2025
RGLS Regulus Therapeutics
Downgrades: Market Perform
7
8.16 -14.22% 3 Apr 30, 2025
MAZE Maze Therapeutics
Initiates Coverage On: Outperform
28
12.29 127.83% 1 Feb 25, 2025
TVTX Travere Therapeutics
Maintains: Outperform
20 40
15.16 163.85% 6 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
11 14
n/a n/a 2 Sep 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 3 Jul 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
12 12
4.68 156.41% 6 Jun 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
6 8
2.68 198.51% 2 Jun 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
9 2
n/a n/a 5 Mar 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
1
1.24 -19.35% 4 Feb 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
10
n/a n/a 3 Dec 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
1
n/a n/a 2 Aug 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
6
3.7 62.16% 4 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
44 40
n/a n/a 3 Jun 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
80 115
n/a n/a 3 Jun 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
48
49.79 -3.6% 1 Mar 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
20 18
16.89 6.57% 5 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
30 20
11.66 71.53% 5 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
33 34
39.73 -14.42% 1 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
122 130
55.12 135.85% 10 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
160
17.1 835.67% 10 Jan 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
148 163
173.35 -5.97% 15 Jan 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
15 2
n/a n/a 6 Dec 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 10
1.21 726.45% 7 Dec 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
40 33
1.2 2650% 2 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
17 12
8.7 37.93% 6 Nov 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
115 108
36.37 196.95% 6 Nov 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
64 52
n/a n/a 5 Aug 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
36 39
30.34 28.54% 1 May 26, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
6 4
0.83 381.93% 4 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
34 30
13.24 126.59% 2 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
53 50
29.48 69.61% 3 May 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
50 30
55.18 -45.63% 6 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
71 56
13.79 306.09% 1 May 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
124 4
46.38 -91.38% 6 Apr 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
16 14
5.87 138.5% 10 Feb 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
112 100
n/a n/a 6 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Dec 12, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
25
n/a n/a 1 Oct 23, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
10 12
2.25 433.33% 1 Sep 26, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
23
n/a n/a 1 Aug 28, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 3 May 18, 2017